{
    "2018-03-01": [
        [
            {
                "time": "2018-03-01",
                "original_text": "速读社丨新基多发性硬化症药物ozanimod遭FDA拒绝",
                "features": {
                    "keywords": [
                        "ozanimod",
                        "FDA",
                        "拒绝",
                        "新基",
                        "多发性硬化症"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[增持评级] 医药与健康护理行业月报：重点关注快报、一季报超预期个股",
                "features": {
                    "keywords": [
                        "增持",
                        "医药",
                        "健康护理",
                        "一季报",
                        "超预期"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[买入评级] 乐普医疗(300003)事件点评：完善心血管药品布局 参与竞拍新东港有望增厚业绩",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "心血管",
                        "药品布局",
                        "竞拍",
                        "新东港",
                        "业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "创业板蓝筹股有哪些: 创业板三连阳飙升5.08% 机构调仓换股力荐17",
                "features": {
                    "keywords": [
                        "创业板",
                        "蓝筹股",
                        "三连阳",
                        "飙升",
                        "机构推荐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[推荐评级] 乐普医疗(300003): 默沙东拟以5.02亿澳元收购乐普参股的溶瘤病毒子公司VIRALYTICS",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "默沙东",
                        "收购",
                        "溶瘤病毒",
                        "VIRALYTICS"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[增持评级] 医药与健康护理行业信息点评：人社部公布按病种付费推荐目录 好国产耗材进口替代",
                "features": {
                    "keywords": [
                        "人社部",
                        "按病种付费",
                        "国产耗材",
                        "进口替代"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}